Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1141, 2007-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New agents tackle resistance in HIV infection
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
Access to resources
Recommend
New safety information for epoetin-α, darbepoetin-α
Reactions Weekly, Vol. 1, Iss. 1149, 2007-01 ,pp. :
FDA: new safety information for recombinant erythropoietins
Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. :
Entecavir: a potent new antiviral drug for hepatitis B
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. :
Entecavir: a new treatment for chronic hepatitis B infection
By Schreibman Ian R Schiff Eugene R
Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. :